Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial.

Source:http://linkedlifedata.com/resource/pubmed/id/8331011

Int. J. Radiat. Oncol. Biol. Phys. 1993 Jul 15 26 4 721-9

Download in:

View as

Triples

General Info

PMID
8331011